Evidence map›Paper›PMID 35936720›Full record

ArticleFrontiers in oncology2022

Dynamic Predictive Models With Visualized Machine Learning for Assessing Chondrosarcoma Overall Survival.

Wenle Li, Gui Wang, Rilige Wu, Shengtao Dong, Haosheng Wang, Chan Xu, Bing Wang, Wanying Li, Zhaohui Hu, Qi Chen and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systematic review of 99 extremity bone malignancy survival prediction models.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenle LiDepartment of Orthopedics, Xianyang Central Hospital, Xianyang, China.
Gui WangDepartment of Orthopaedics, Hainan Western Central Hospital, Danzhou, China.
Rilige WuFaculty of Science Beijing University of Posts and Telecommunications, Beijing, China.
Shengtao DongDepartment of Spine Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Haosheng WangDepartment of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Chan XuClinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Bing WangClinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Wanying LiClinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Zhaohui HuDepartment of Spine Surgery, Liuzhou People's Hospital, Liuzhou, China.
Qi ChenMicrobial Resource and Big Data Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Chengliang YinFaculty of Medicine, Macau University of Science and Technology, Macao SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondrosarcoma is a malignant bone tumor with a low incidence rate. Accurate risk evaluation is crucial for chondrosarcoma treatment. Due to the limited reliability of existing predictive models, we intended to develop a credible predictor for clinical chondrosarcoma based on the Surveillance, Epidemiology, and End Results data and four Chinese medical institutes. Three algorithms (Best Subset Regression, Univariate and Cox regression, and Least Absolute Shrinkage and Selector Operator) were used for the joint training. A nomogram predictor including eight variables-age, sex, grade, T, N, M, surgery, and chemotherapy-is constructed. The predictor provides good performance in discrimination and calibration, with area under the curve ≥0.8 in the receiver operating characteristic curves of both internal and external validations. The predictor especially had very good clinical utility in terms of net benefit to patients at the 3- and 5-year points in both North America and China. A convenient web calculator based on the prediction model is available at https://drwenle029.shinyapps.io/CHSSapp, which is free and open to all clinicians.

Indexed as

chondrosarcomamulticenternomogramprediction modelweb calculator

Identifiers

PMID35936720
PMCPMC9351692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.